• Pages

  • Recent Posts

  • Archives

  • Subscribe Via Email

  • Categories

  • Tags

  • Meta

  • « | Home | »

    Cholesterol Lowering Drugs are Worthless in Most Cases – Part Two

    By Mark Schauss | February 18, 2008

    In one of my blogs last week, I talked about the issues with Lipitor® and the lack of the association between high cholesterol and coronary heart disease. Now let’s talk about real problems that come up by taking this drug.

    Say the side-effect rate is 3-5% (which is the pharmaceutical industry line) which means that given one-percent of people get a benefit, five-percent get side-effects that can be rather serious. Guess what? That estimate is way under what practitioners in the field are seeing. Reports indicate that in the real world the side-effect rate is closer to 15%.

    Obviously, this would mean that we need to move away from pharmaceutical intervention to lower cholesterol to alternative, “natural” ones right? Wrong. Turns out cholesterol levels in people with heart disease are not really much higher than people without heart disease. Also, low cholesterol (under 160mg/dl) may increase the risk of a number of health disorders like stroke, cancer, depression, and suicide. Lowering cholesterol is not the issue, in spite of what the nutraceutical industry would like you to believe. They are being no different in their claims than the pharmaceutical industry.

    The real culprit in heart disease is inflammation. Lower inflammation and not only do you lower the real risk for heart disease , you lower the risks for a myriad of other diseases from diabetes to arthritis, from cancer to migraines, seizures and irritable bowel syndrome to name a few.

    Topics: Drugs, Health, Opinion, Research | No Comments »

    Comments